Oppenheimer Asset Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,029
Closed -$16K 1425
2020
Q1
$16K Sell
3,029
-87
-3% -$595 ﹤0.01% 1401
2019
Q4
$23K Buy
3,116
+1,320
+73% +$10.9K ﹤0.01% 1441
2019
Q3
$16K Buy
1,796
+44
+3% +$377 ﹤0.01% 1474
2019
Q2
$14K Sell
1,752
-40
-2% -$364 ﹤0.01% 1508
2019
Q1
$18K Buy
+1,792
New +$16.1K ﹤0.01% 1463

Other funds holding ULBI

Oppenheimer Asset Management's ULBI Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Ultralife (ULBI) in Q2 2020, closing a stake of 3,029 shares — an estimated $16K sold.

Oppenheimer Asset Management first reported a position in ULBI in Q1 2019 and held it in 5 quarters. The position peaked at $23K in Q4 2019. 46 funds tracked by Wall St. Rank hold ULBI as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining Ultralife position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 3,029 Ultralife shares in Q2 2020, an estimated $16K.
  • Oppenheimer Asset Management first reported a position in Ultralife in Q1 2019 and held it in 5 quarters.
  • Oppenheimer Asset Management's Ultralife position peaked at $23K in Q4 2019.
  • 46 funds tracked by Wall St. Rank held Ultralife as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.